Saudi Healthcare Providers’ Perspectives and Clinical Practice of Anti-Obesity Medications: A National Survey
Background: The rising prevalence of obesity is associated with significant health risks, underscoring the need for effective prevention and treatment. The use of anti-obesity medications (AOMs) remains limited due to several barriers. Objectives: To physicians’ perspectives and clinical practices r...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-07-01
|
| Series: | Saudi Journal of Medicine and Medical Sciences |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/sjmms.sjmms_672_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849243699546947584 |
|---|---|
| author | Haifa F. AlOtaibi Sahar Alnasrallah Assim A. Alfadda Samar A. Alquassayer Amr A. Arafat Shadan AlMuhaidib Rawabi M. Alsayer Saleh A. Alqahtani Waleed Alhazzani |
| author_facet | Haifa F. AlOtaibi Sahar Alnasrallah Assim A. Alfadda Samar A. Alquassayer Amr A. Arafat Shadan AlMuhaidib Rawabi M. Alsayer Saleh A. Alqahtani Waleed Alhazzani |
| author_sort | Haifa F. AlOtaibi |
| collection | DOAJ |
| description | Background:
The rising prevalence of obesity is associated with significant health risks, underscoring the need for effective prevention and treatment. The use of anti-obesity medications (AOMs) remains limited due to several barriers.
Objectives:
To physicians’ perspectives and clinical practices regarding AOMs in Saudi Arabia.
Methods:
We conducted a national cross-sectional survey between May and August 2024 targeting family physicians, endocrinologists, and bariatric surgeons in Saudi Arabia. We distributed the survey using convenience sampling through department heads at hospitals across five regions and relevant professional societies. We collected data on clinician demographics, clinical practices, and perceptions related to AOMs. We compared responses across specialties and identified predictors of prescribing AOMs.
Results:
A total of 92 clinicians completed the survey: 71 family physicians, 20 endocrinologists, and 1 bariatric surgeon. Overall, 15.3% of the respondents had received formal obesity-focused training. While 92.4% reported counseling patients on obesity-related complications, 57.6% routinely referred patients to dietitians. Endocrinologists preferred international guidelines and prescribed AOMs more frequently than family physicians (90.0% vs. 60.5%; P < 0.001). Glucagon-like peptide-1 receptor agonists were the most commonly prescribed first-line agents. Key predictors of prescribing AOMs included medical specialty, guidelines preference, and prior obesity training.
Conclusions:
Physician specialty, clinical experience, and adherence to guidelines influence the prescription of anti-obesity medications in Saudi Arabia. Limited training and a more conservative approach among family physicians highlight the need for targeted educational interventions to improve obesity management. Initiatives should focus on harmonizing clinical guidelines and expanding access to evidence-based treatments. |
| format | Article |
| id | doaj-art-d74de648a9b14ed9a1c7b4d60bcc0ae6 |
| institution | Kabale University |
| issn | 1658-631X 2321-4856 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Saudi Journal of Medicine and Medical Sciences |
| spelling | doaj-art-d74de648a9b14ed9a1c7b4d60bcc0ae62025-08-20T03:59:22ZengWolters Kluwer Medknow PublicationsSaudi Journal of Medicine and Medical Sciences1658-631X2321-48562025-07-0113322223010.4103/sjmms.sjmms_672_24Saudi Healthcare Providers’ Perspectives and Clinical Practice of Anti-Obesity Medications: A National SurveyHaifa F. AlOtaibiSahar AlnasrallahAssim A. AlfaddaSamar A. AlquassayerAmr A. ArafatShadan AlMuhaidibRawabi M. AlsayerSaleh A. AlqahtaniWaleed AlhazzaniBackground: The rising prevalence of obesity is associated with significant health risks, underscoring the need for effective prevention and treatment. The use of anti-obesity medications (AOMs) remains limited due to several barriers. Objectives: To physicians’ perspectives and clinical practices regarding AOMs in Saudi Arabia. Methods: We conducted a national cross-sectional survey between May and August 2024 targeting family physicians, endocrinologists, and bariatric surgeons in Saudi Arabia. We distributed the survey using convenience sampling through department heads at hospitals across five regions and relevant professional societies. We collected data on clinician demographics, clinical practices, and perceptions related to AOMs. We compared responses across specialties and identified predictors of prescribing AOMs. Results: A total of 92 clinicians completed the survey: 71 family physicians, 20 endocrinologists, and 1 bariatric surgeon. Overall, 15.3% of the respondents had received formal obesity-focused training. While 92.4% reported counseling patients on obesity-related complications, 57.6% routinely referred patients to dietitians. Endocrinologists preferred international guidelines and prescribed AOMs more frequently than family physicians (90.0% vs. 60.5%; P < 0.001). Glucagon-like peptide-1 receptor agonists were the most commonly prescribed first-line agents. Key predictors of prescribing AOMs included medical specialty, guidelines preference, and prior obesity training. Conclusions: Physician specialty, clinical experience, and adherence to guidelines influence the prescription of anti-obesity medications in Saudi Arabia. Limited training and a more conservative approach among family physicians highlight the need for targeted educational interventions to improve obesity management. Initiatives should focus on harmonizing clinical guidelines and expanding access to evidence-based treatments.https://journals.lww.com/10.4103/sjmms.sjmms_672_24anti-obesity medicationsglp-1 receptor agonistsobesitysaudi arabiasurvey |
| spellingShingle | Haifa F. AlOtaibi Sahar Alnasrallah Assim A. Alfadda Samar A. Alquassayer Amr A. Arafat Shadan AlMuhaidib Rawabi M. Alsayer Saleh A. Alqahtani Waleed Alhazzani Saudi Healthcare Providers’ Perspectives and Clinical Practice of Anti-Obesity Medications: A National Survey Saudi Journal of Medicine and Medical Sciences anti-obesity medications glp-1 receptor agonists obesity saudi arabia survey |
| title | Saudi Healthcare Providers’ Perspectives and Clinical Practice of Anti-Obesity Medications: A National Survey |
| title_full | Saudi Healthcare Providers’ Perspectives and Clinical Practice of Anti-Obesity Medications: A National Survey |
| title_fullStr | Saudi Healthcare Providers’ Perspectives and Clinical Practice of Anti-Obesity Medications: A National Survey |
| title_full_unstemmed | Saudi Healthcare Providers’ Perspectives and Clinical Practice of Anti-Obesity Medications: A National Survey |
| title_short | Saudi Healthcare Providers’ Perspectives and Clinical Practice of Anti-Obesity Medications: A National Survey |
| title_sort | saudi healthcare providers perspectives and clinical practice of anti obesity medications a national survey |
| topic | anti-obesity medications glp-1 receptor agonists obesity saudi arabia survey |
| url | https://journals.lww.com/10.4103/sjmms.sjmms_672_24 |
| work_keys_str_mv | AT haifafalotaibi saudihealthcareprovidersperspectivesandclinicalpracticeofantiobesitymedicationsanationalsurvey AT saharalnasrallah saudihealthcareprovidersperspectivesandclinicalpracticeofantiobesitymedicationsanationalsurvey AT assimaalfadda saudihealthcareprovidersperspectivesandclinicalpracticeofantiobesitymedicationsanationalsurvey AT samaraalquassayer saudihealthcareprovidersperspectivesandclinicalpracticeofantiobesitymedicationsanationalsurvey AT amraarafat saudihealthcareprovidersperspectivesandclinicalpracticeofantiobesitymedicationsanationalsurvey AT shadanalmuhaidib saudihealthcareprovidersperspectivesandclinicalpracticeofantiobesitymedicationsanationalsurvey AT rawabimalsayer saudihealthcareprovidersperspectivesandclinicalpracticeofantiobesitymedicationsanationalsurvey AT salehaalqahtani saudihealthcareprovidersperspectivesandclinicalpracticeofantiobesitymedicationsanationalsurvey AT waleedalhazzani saudihealthcareprovidersperspectivesandclinicalpracticeofantiobesitymedicationsanationalsurvey |